News & updates

Chronic respiratory disease often gets misinterpreted as an infection across the globe

Created on:


December 16, 2021

Wednesday, December 15th 2021, marks a special day as medical journal The Lancet Global Health published a new mixed-method study on mapping low-resource contexts to prepare for lung health interventions in four countries, conducted by the ‘FRESH AIR collaborators’. This international research group, led by the LUMC, found worryingly that chronic respiratory disease (CRD) often gets misinterpreted as an infection, especially as tuberculosis. The study found three themes to address that might prove pivotal for adequate implementation of interventions for CRD.

About FRESH AIR

About 80 million people suffer from chronic obstructive pulmonary disease (COPD) globally and a further 300 million are affected by asthma. The greatest burden of CRD occurs in low-resource settings. Most studies have, however, focused on creating an evidence-base for treatments of CRD in high-resource settings. Little is known about the application of this evidence-base to low-resource settings, contextual risk factors, and barriers that hamper implementation.

FRESH AIR is a three-year Horizon 2020 research project that addresses the urgent need to prevent, diagnose and treat lung diseases in diverse low-resource settings. It consists of several studies conducted in Uganda, Kyrgyzstan, Vietnam and Greece. The overall aim is to improve health outcomes by developing capacity for implementation of evidence-based interventions in these contexts.

This FRESH AIR study and its findings

Effectiveness of health programmes can be undermined when the implementation misaligns with local beliefs and behaviours. For the current study, the group explored beliefs and behaviours regarding CRD in aforementioned low-resource settings with the aim to design context-driven implementation strategies for CRD interventions. 340 villagers and health professionals were interviewed and observed during the study. Additionally, a questionnaire was filled out by 1037 villagers and 204 health professionals. Uniquely, the exact same evidence-based approach was utilized in each of the countries.

The research surprisingly showed that in each of the studied countries, the exact same three themes play a key role in CRD related beliefs and behaviours. Firstly, identification of the disease is an important theme. In these low-resource settings, apart from Greece, chronic diseases are rarely thought of and get mistaken for infections. Secondly, insight into causes of CRD or lacking. Even though smoking is considered a known risk, there is little to no attention to air pollution indoors (for instance by cooking on wood or dung, practices exercised by three billion people daily). Thirdly, the team found social norms and structures to determine CRD related behaviour, for instance in Kyrgyzstan and Vietnam, where ‘real men’ smoke.

Next steps

These themes are vital to address when implementing lung health programs in such settings. Previous studies have already shown that if healthcare programs misalign with social behaviours and convictions regarding disease, they are very likely to fail. This causes valuable resources to be wasted, which are already scarce in these settings. When designing context-driven implementation strategies for CRD-related interventions across these global settings, the three consistent themes should be addressed, each with common and context-specific beliefs and behaviours. Context-driven strategies can reduce the risk of implementation failure, thereby optimizing resource use to benefit health outcomes.

Read the article in The Lancet here.


More news & updates

AE-TBC wins EDCTP’s Outstanding Research Team 2020 prize!

November 2, 2021

The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.

Background Image Of A Scientist Recording Test Results In A Lab

Janssen COVID-19 vaccine approved for use in EU on March 11

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

VODAN-Africa Health System is being deployed across 88 health facilities in 8 African countries

April 21, 2022

“This is an achievement in alignment with the mission of VODAN-Africa to generate continuous, real-time, high velocity clinical observational patient data from resource-limited communities that have not been well represented in digital health data. The key feature is that the data produced remains in the health facility only. It will not leave the health facility. Since the data is machine-actionable the input of the data only happens once; in the deployable architecture, the data is used for four parallel use cases” (VODAN to Africa, 2022).

Stay up to date with news, inspirations and events.

© LUMC Global. All rights reserved. Website door philogirl

Contact

Social